Credit Suisse Ag Biogen Inc. Put Options Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

Put Options

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $2.17 Million - $2.79 Million	9,700 Added 186.54%	14,900 $3.58 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $17.4 Million - $22.7 Million	-61,600 Reduced 92.22%	5,200 $1.47 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $15.4 Million - $24.7 Million	-59,500 Reduced 47.11%	66,800 $23.1 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $8.89 Million - $10.4 Million	-36,600 Reduced 22.47%	126,300 $35.3 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $20.1 Million - $30.3 Million	85,200 Added 109.65%	162,900 $39.9 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $3.12 Million - $3.61 Million	-11,800 Reduced 13.18%	77,700 $22 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $7.16 Million - $9.49 Million	-27,700 Reduced 23.63%	89,500 $23.9 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $22.5 Million - $28.6 Million	-83,800 Reduced 41.69%	117,200 $37.1 Million
Q4 2019 Feb 12, 2020	BUY	$220.06 - $304.07 $6.6 Million - $9.12 Million	30,000 Added 17.54%	201,000 $59.6 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $12 Million - $13.5 Million	55,400 Added 47.92%	171,000 $39.8 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $6.4 Million - $7.06 Million	29,200 Added 33.8%	115,600 $27 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $2.32 Million - $3.63 Million	10,700 Added 14.13%	86,400 $20.4 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $17.9 Million - $22.7 Million	-64,300 Reduced 45.93%	75,700 $22.8 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $24.9 Million - $32.6 Million	85,000 Added 154.55%	140,000 $49.5 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $6.7 Million - $7.98 Million	26,000 Added 89.66%	55,000 $16 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $7.54 Million - $10.7 Million	29,000 New	29,000 $7.94 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account